Trending Now

LFJ Dealmakers Panel: Opportunities at the Intersection of Funding, Mass Torts & ABS

LFJ Dealmakers Panel: Opportunities at the Intersection of Funding, Mass Torts & ABS

The panel discussion consisted of Jacob Malherbe, CEO of X Social Media, Sara Papantonio, Partner at Levin Papantonio Rafferty, and Ryan Stephen, Managing Partner of Pine Valley Capital Partners. The panel was moderated by Steve Nober, CEO of Consumer Attorney Marketing Group (CAMG), The discussion spanned the following topics:
  • Who’s doing what in mass torts? How about funding?
  • How funders are evaluating and working with firms
  • Examples of the ABS framework in action & challenges
  • Pre- and post-settlement funding and time to disbursement
The conversation began around the integration of litigation funders into the mass torts sector. There are a lot of variables to consider around mass torts which typically don’t exist in other case types. These include marketing ethics, use of proceeds, claimant access and relationship building, where the call center is located, firm operations at an administrative level, etc. These are all aspects of a law firm that litigation funders need to understand if they are going to partner with a mass torts law firm. The degree of diligence is vast, and will require a years-long commitment. What’s more, there is now a focus on unethical marketing practices, with Congress taking a look at the tactics being used. The question for funders is, how can you protect yourself from unethical marketing efforts (funders might be named in a suit against the law firm). Funders need to mitigate these risks by asking more questions at the outset: What kind of advertising is being used, where are the clients coming from, how do I know that the clients are real (ad tracking)? Too many funders are pouring money into this lucrative space, and run the risk of encountering scammers who set up a business looking to raise money for a mass torts claim, when they have no ability to secure claimants or conduct the proper marketing outreach. What this comes down to at its core is relationships—understanding and knowing who you’re working with. Funders need to feel that the law firm they partner with us trustworthy, but of course should still conduct their own diligence to verify that all activities are on the up and up. On this last point, the panel recommends creating more nuanced tracking—not just ‘cost per case.’ Track advertising costs, medical records, other marketing materials. Really understand how money is moving at a granular level. The discussion then pivoted over to the Camp Lejeune case. Sara Papantonio feels that there will be one more opportunity to make a push for cases when payouts start happening. The question is, will there be enough time to advertise and file a claim before the statute of limitations runs out? Papantonio also noted that many clients won’t qualify for the elective option, and those that do probably won’t take it because of how undervalued it is. So likely, we will see more cases move into litigation. Values are starting to be presented for Tier 1 and Tier 2 injuries, which will help push this into litigation as well. She believes around May of 2024 will be an opportunity to advertise, but the statute of limitations runs out in August. Papantonio explained that Tier 1 injuries are far less risk for funders and litigators. Tier 2s and Tier 3s will have to move through a process, and some won’t be approved, so there is more risk there. Papantonio also believes the fees will be capped at 20-25%, which was the DOJs recommendation. So funders and law firms should plan for that. One final point Papantonio made, was that these mega mass torts are sucking up all the oxygen in the space, but there are plenty of smaller torts that are very meritorious and present opportunities for funders and law firms. The panel concurred, given that $1 billion has spent on Camp Lejeune already, so any new entrants into that claim are coming in late stage. Panelists Ryan Stephen and Jacob Malherbe added that torts such as Tylenol, Roundup part two, paraquat, PFAS claim (which the panel believes might become the biggest case ever), anti-terrorism cases, and others. Malherbe even recommended ‘The Devil We Know,’ a documentary on Netflix about the PFAS claim—so anyone interested can follow up with some binge watching!

Commercial

View All

Sony Defeats £2bn Funded PlayStation Class Action at the CAT

The Competition Appeal Tribunal has dismissed the Woodsford-funded class action against Sony in its entirety, ending a claim that once carried a headline value of up to £5bn and stood at roughly £1.97bn including interest by the time it reached trial.

As reported by Law News, the Tribunal ruled unanimously in *Alex Neill Class Representative Limited v Sony Interactive Entertainment Europe Limited and another* [2026] CAT 86, handed down Tuesday. The panel of Ben Tidswell, Lord Richardson and Derek Ridyard concluded that "the Class Representative has failed to establish that Sony has infringed competition law."

Filed in August 2022 on behalf of around 12.2 million UK PlayStation owners, the claim alleged that Sony's 30% commission on PlayStation Store sales inflated prices by roughly 20% across a class period running from August 2016 to February 2026. Following a ten-week trial between March and May 2026, the Tribunal found against the class representative on every substantive issue.

Market definition proved decisive. The Tribunal rejected the proposed PlayStation-only aftermarket, finding that physical games and rival platforms constrained Sony's pricing, and was not satisfied Sony held a dominant position on any relevant market. It also found the 30% commission was neither excessive nor unfair. The class representative had advanced no alternative market definition and accepted in closing that the claim would fail on such a finding.

The outcome contrasts sharply with the same Tribunal's conclusion in *Kent v Apple* that Apple's equivalent App Store commission was abusive. Alex Neill said she was disappointed and is weighing options including an appeal. A further hearing on costs and permission to appeal is set for the week beginning 14 December.

United Petroleum Sues Funder Over $222M Class Action Investment Pitch

United Petroleum has launched proceedings against the litigation funder backing a franchisee class action against it, alleging the funder misled investors by marketing the claim as worth $222 million — a figure the company says appears nowhere in the court filings.

As reported by Lawyerly, the fuel retailer's claim targets Knightsbridge Litigation Funding and revives an argument that has circled Australian class actions for years: that funded group proceedings should be registered and regulated as managed investment schemes.

The underlying class action, *FNH United and others v United Petroleum Franchise and others*, was filed in the Supreme Court of Victoria in October 2022 and concerns the allocation of Pie Face stock to franchisees. It is funded by Knightsbridge Litigation Funding Pty Ltd and UP Capital Pty Ltd as trustee for the UP Litigation Funding Unit Trust, on a commission of 33%, with Hong Kong-based Golden Crane acting as co-funder.

The dispute over the funder's investor materials has been building since September, when United Petroleum's lawyers at King & Wood Mallesons referred the funders to the Australian Securities and Investments Commission over an investor briefing that cited a A$222m "pleaded value" for the case and projected returns of up to 400%. United Petroleum maintains those figures do not correspond to anything in the pleadings.

The new proceeding moves the fight from a regulatory referral into open court, and places the question of how funders describe their cases to prospective investors — and what legal consequences follow if those descriptions are wrong — squarely before a judge.

LCM Writes Off A$7.7m as Quintis Shareholder Appeal Fails

Litigation Capital Management has written off its entire remaining investment in the Quintis shareholder class action after the Full Court of the Federal Court of Australia dismissed the applicants' appeal, marking the third adverse case disclosure from the AIM-listed funder in roughly six weeks.

As reported by Lawyerly, the Full Court rejected the shareholders' challenge to the first-instance judgment in the claim brought against Quintis founder Frank Wilson and auditor EY. LCM confirmed the outcome in a regulatory announcement headed "Appeal Unsuccessful," published the morning of 18 November 2026.

The investment had been carried at A$7.7m as at 30 June 2026 and will now be written off in full. LCM had committed A$13.2m of its own balance sheet capital to the case. The company's shares fell roughly 28% in early London trading following the announcement.

The underlying judgment, delivered by Justice Shariff in February 2025, produced an unusual result: the court found that the former director and EY had engaged in misleading and deceptive conduct, but dismissed the class action because the applicants failed to establish causation or any compensable loss. It was the sixth Australian shareholder class action to fail at trial, and costs were awarded against the applicants with the funder jointly and severally liable. The Full Court heard the appeal over five days in March 2026.

The write-off follows LCM's disclosure on 9 November that permission to appeal had been refused in a separate commercial matter carrying a £5.0m investment, and an October judgment against it in a funded insolvency claim valued at A$2.9m. LCM reported a net realised loss of A$63.9m for FY2026, against a A$22.2m gain the prior year.